Work

ARTEMISIA: A JAK1 inhibitor mechanistic study to advance molecular understanding and precision medicine in respiratory diseases

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa342

Authors: Zala Jevnikar Rojnik, Davinder P S Dosanjh, Tina Jellesmark Jensen, Erika Darrah, Jenny Torell, Alese Halvorson, Mathias Cardner, Camille Riff, Daniel Muthas, Chris Chamberlain, Adam Platt, Maria G Belvisi, Rod Hughes, Kyriakos V. Konstantinidis, Christopher E. Brightling

Institutions: AstraZeneca (Sweden), AstraZeneca (United Kingdom), AstraZeneca (United States), University of Leicester, NIHR Leicester Biomedical Research Centre

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404104658

Cites:

Cited by: 1

Related to: 10